Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for QPT.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
January 31, 2026 27.75M
October 31, 2025 24.33M
July 31, 2025 23.09M
April 30, 2025 23.16M
January 31, 2025 22.56M
October 31, 2024 24.20M
July 31, 2024 24.08M
April 30, 2024 23.43M
January 31, 2024 24.48M
October 31, 2023 26.24M
July 31, 2023 26.87M
April 30, 2023 26.59M
January 31, 2023 84.36M
October 31, 2022 89.10M
July 31, 2022 89.98M
April 30, 2022 90.54M
January 31, 2022 91.03M
October 31, 2021 166.62M
July 31, 2021 175.67M
April 30, 2021 175.04M
January 31, 2021 175.61M
October 31, 2020 112.51M
July 31, 2020 108.47M
April 30, 2020 105.30M
January 31, 2020 4.452M
Date Value
October 31, 2019 3.237M
July 31, 2019 4.898M
April 30, 2019 6.851M
January 31, 2019 5.810M
October 31, 2018 8.099M
July 31, 2018 9.273M
April 30, 2018 11.62M
January 31, 2018 12.78M
October 31, 2017 12.83M
July 31, 2017 12.96M
April 30, 2017 10.15M
January 31, 2017 11.37M
October 31, 2016 12.59M
July 31, 2016 13.77M
April 30, 2016 10.59M
January 31, 2016 10.87M
October 31, 2015 2.178M
July 31, 2015 0.6631M
April 30, 2015 0.2501M
January 31, 2015 0.332M
October 31, 2014 0.2551M
July 31, 2014 0.3565M
April 30, 2014 0.2038M
January 31, 2014 0.9019M
October 31, 2013 0.3746M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Kane Biotech, Inc. 1.811M
BriaCell Therapeutics Corp. 36.85M
Vaxil Bio Ltd. 1.224M
Waverley Pharma, Inc. 1.195M
Goldcoast Resource Corp. 0.8168M

Total Assets (Quarterly) Related Metrics